Literature DB >> 22369184

Differing clinical features in Aboriginal vs. non-Aboriginal children presenting with type 2 diabetes.

Shazhan Amed1, Jill K Hamilton, Elizabeth A C Sellers, Constadina Panagiotopoulos, Stasia Hadjiyannakis, Baiju R Shah, Gillian L Booth, Tessa A Laubscher, David Dannenbaum, Heather Dean.   

Abstract

OBJECTIVES: Childhood type 2 diabetes (T2D) is increasing and may present differently across various populations. This study compares clinical features of T2D at diagnosis in Aboriginal children with Caucasian children and children from other high-risk ethnic groups. PATIENTS AND METHODS: This retrospective observational study used data from a Canadian surveillance study where newly diagnosed cases of childhood T2D were reported (n = 227). Using descriptive statistics, clinical features at diagnosis of T2D were compared across different ethnic groups including Aboriginal (n = 100), Caucasian (n = 57), and other high-risk ethnic groups (n = 64). Comparisons were made between Aboriginal children living in central Canada (Manitoba/northwestern Ontario) (n = 74) and Aboriginal children from other regions of Canada (n = 26).
RESULTS: Aboriginal children were younger, less obese, and less likely to have polycystic ovarian syndrome and dyslipidemia when compared to Caucasian children and children from other high-risk ethnic groups (p < 0.05). Aboriginal children from central Canada vs. those from other regions of Canada did not differ in age, body mass index z-score, family history of T2D, or presence of acanthosis nigricans. Those from central Canada had lower hemoglobin A1c levels (p < 0.05) and were less likely to have dyslipidemia than Aboriginal children from other regions (p < 0.05).
CONCLUSIONS: Clinical features and rates of comorbidity in children with newly diagnosed T2D differ across various populations (Caucasian, Aboriginal, and children who belong to other high-risk ethnic groups) and across distinct Aboriginal populations (those living in central Canada vs. those living in other regions of Canada). Future research should determine specific genetic and environmental factors that contribute to these differences.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 22369184     DOI: 10.1111/j.1399-5448.2012.00859.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  4 in total

Review 1.  Metabolic basis of ethnic differences in diabetes risk in overweight and obese youth.

Authors:  Tanya L Alderete; Claudia M Toledo-Corral; Michael I Goran
Journal:  Curr Diab Rep       Date:  2014-02       Impact factor: 4.810

2.  Prevalence of Polycystic Ovary Syndrome in Patients With Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis.

Authors:  Milena Cioana; Jiawen Deng; Ajantha Nadarajah; Maggie Hou; Yuan Qiu; Sondra Song Jie Chen; Angelica Rivas; Laura Banfield; Haifa Alfaraidi; Ahlam Alotaibi; Lehana Thabane; M Constantine Samaan
Journal:  JAMA Netw Open       Date:  2022-02-01

3.  Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis.

Authors:  Caiyi Long; Haoyue Feng; Wen Duan; Xin Chen; Yuemeng Zhao; Ying Lan; Rensong Yue
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-31       Impact factor: 6.055

4.  The prevalence of undiagnosed Prediabetes/type 2 diabetes, prehypertension/hypertension and obesity among ethnic groups of adolescents in Western Canada.

Authors:  Shelley Spurr; Jill Bally; Carol Bullin; Diane Allan; Erick McNair
Journal:  BMC Pediatr       Date:  2020-01-23       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.